Smoke-Free Living Study

PHASE1CompletedINTERVENTIONAL
Enrollment

100

Participants

Timeline

Start Date

January 31, 2008

Primary Completion Date

November 30, 2011

Study Completion Date

November 30, 2011

Conditions
Additional, Effective Methods to Stop Smoking
Interventions
BEHAVIORAL

Extended IVR (integrated voice response technology)

See detailed description

DRUG

Varenicline (Champix)

See detailed description

BEHAVIORAL

IVR treatment

See detailed description

Trial Locations (1)

V6Z 1Y6

Healthy Heart Program, St. Paul's Hospital, Vancouver

Sponsors

Collaborators (1)

All Listed Sponsors
collaborator

Pfizer

INDUSTRY

lead

University of British Columbia

OTHER

NCT00832806 - Smoke-Free Living Study | Biotech Hunter | Biotech Hunter